IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -23.1% | 27,784 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -51.9% | 27,784 | -49.3% | 0.00% | – |
| Q1 2022 | $27,000 | +92.9% | 54,773 | +306.1% | 0.00% | – |
| Q3 2021 | $14,000 | -12.5% | 13,488 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -11.1% | 13,488 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | -67.9% | 13,488 | -11.1% | 0.00% | – |
| Q4 2020 | $56,000 | -93.8% | 15,167 | -95.7% | 0.00% | -100.0% |
| Q1 2019 | $907,000 | -21.3% | 355,728 | -14.5% | 0.01% | -30.8% |
| Q4 2018 | $1,153,000 | – | 416,241 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |